Based on observation, interview, record review, and policy review, the provider failed to ensure one of one sampled resident (6) observed to have Cortisone 10 (a medicated steroid cream that is used on the skin to treat inflammation and itching) and a container labeled Hempvona cream (a topical cream with hemp-seed oil) located on his bedside table was evaluated for his ability to safely self-administer those medications.1. Observation and interview on 7/28/26 at 10:15 a.m. with resident 6 in his room revealed a tube of Cortisone 10 and a container labeled Hempvona cream. The resident used the Cortisone 10 for facial itching and the Hempvona cream for discomfort. He did not know if the staff knew he had it.2. Observation on 7/29/26 at 2:20 p.m. …
F554 citations in South Dakota
Resident Rights Deficiencies
Allow residents to self-administer drugs if determined clinically appropriate.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
South Dakota cites F554 more often than its own record predicts
3.85 times the share F554 takes of citations nationally.
Of every deficiency written in South Dakota in 2025, this is the portion that was F554.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What South Dakota surveyors wrote
F554 findings written in South Dakota, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
The short window
Recent years
| Year | Share of South Dakota citations | vs expected |
|---|---|---|
| 2023 | 0.72% | 1.31× |
| 2024 | 0.22% | 0.41× |
| 2025 | 2.18% | 3.85× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else South Dakota surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction